(-0.09%) 5 464.54 points
(-0.06%) 39 090 points
(0.15%) 17 744 points
(-0.71%) $80.26
(-4.32%) $2.64
(-0.85%) $2 311.00
(-0.01%) $28.87
(2.30%) $1 009.10
(0.30%) $0.936
(0.71%) $10.68
(0.50%) $0.792
(-0.27%) $87.26
Live Chart Being Loaded With Signals
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide...
Stats | |
---|---|
Today's Volume | 8.20M |
Average Volume | 996 380 |
Market Cap | 0.00 |
EPS | $-0.490 ( Q1 | 2021-05-05 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.39 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.159 (4.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-08-05 | Stonepine Capital, L.p. | Sell | 6 770 000 | Common Stock |
2021-08-05 | Ludlam William | Sell | 11 799 | Common Stock |
2021-08-05 | Ludlam William | Sell | 45 916 | Stock Option (Right to Buy) |
2021-08-05 | Ludlam William | Sell | 14 531 | Stock Option (Right to Buy) |
2021-08-05 | Ludlam William | Sell | 74 997 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
0.00 |
Last 99 transactions |
Buy: 1 667 356 | Sell: 11 115 504 |
Volume Correlation
Chiasma, Inc. Correlation
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Chiasma, Inc. Correlation - Currency/Commodity
Chiasma, Inc. Financials
Annual | 2020 |
Revenue: | $1.11M |
Gross Profit: | $1.05M (94.48 %) |
EPS: | $-1.430 |
FY | 2020 |
Revenue: | $1.11M |
Gross Profit: | $1.05M (94.48 %) |
EPS: | $-1.430 |
FY | 2019 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.060 |
FY | 2018 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.280 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Chiasma, Inc.
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators